Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_assertion type Assertion NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_head.
- NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_provenance.
- NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_assertion evidence source_evidence_literature NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_provenance.
- NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_assertion SIO_000772 20530282 NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_provenance.
- NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_assertion wasDerivedFrom gad-20150221 NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_provenance.
- NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_assertion wasGeneratedBy ECO_0000203 NP79338.RAr4hhUfKM65eZZnycSTaDxqPk9HDZJQevxO1lfwBDbTA130_provenance.